Delving into the Latest Updates on SynRx Therapeutics Co., Ltd. with Synapse

Overview

Tags

Neoplasms

Nervous System Diseases

Endocrinology and Metabolic Disease

Small molecule drug

Chemical drugs

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Neoplasms	9
Endocrinology and Metabolic Disease	1
Nervous System Diseases	1

Top 5 Drug Type	Count

Small molecule drug	7
Chemical drugs	2

Top 5 Target	Count

POLQ(DNA polymerase theta)	2
PARG(Poly(ADP-ribose) glycohydrolase)	2

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 06 Feb 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Discovery

3

4

Preclinical

IND Application

1

Phase 1 Clinical

Login to view more data

Current Projects

Drug(Targets)	Indications	Global Highest Phase

SYN818 ( POLQ )	BRCA mutation positive Breast Cancer More	Phase 1
SY-001	Solid tumor More	IND Application
SY-002	Solid tumor More	Preclinical
SYX3759 ( PARG )	Neoplasms More	Preclinical
SYN608 ( PARG )	Neoplasms More	Preclinical